{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:20:18Z","timestamp":1788254418411,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejogrb.2022.04.016","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T02:12:11Z","timestamp":1650507131000},"page":"54-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Anti-M\u00fcllerian hormone, an ovarian reserve marker in hypogonadotropic hypogonadism"],"prefix":"10.1016","volume":"273","author":[{"given":"Mahmut","family":"Oncul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipek Betul","family":"Ozcivit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafer","family":"Basibuyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren","family":"Cebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezai","family":"Sahmay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejogrb.2022.04.016_b0005","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1210\/jc.2012-3550","article-title":"Approach to the patient with hypogonadotropic hypogonadism","volume":"98","author":"Silveira","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.04.016_b0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/0974-1208.92283","article-title":"Ovarian reserve tests","volume":"4","author":"Jirge","year":"2011","journal-title":"J Hum Reprod Sci"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.04.016_b0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajog.2017.02.027","article-title":"Ovarian reserve testing: a user\u2019s guide","volume":"217","author":"Tal","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2022.04.016_b0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.maturitas.2017.04.018","article-title":"Anti-M\u00fcllerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years","volume":"102","author":"Kim","year":"2017","journal-title":"Maturitas"},{"issue":"07","key":"10.1016\/j.ejogrb.2022.04.016_b0025","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1055\/a-0840-3817","article-title":"Is there a need to alter the timing of anti-m\u00fcllerian hormone measurement during the menstrual cycle?","volume":"79","author":"Gorkem","year":"2019","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.04.016_b0030","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.fertnstert.2012.07.1118","article-title":"Serum levels of antim\u00fcllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist","volume":"98","author":"Hagen","year":"2012","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.04.016_b0035","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2016-3799","article-title":"Anti-M\u00fcllerian hormone and ovarian morphology in women with isolated hypogonadotropic hypogonadism\/Kallmann syndrome: effects of recombinant human FSH","volume":"102","author":"Bry-Gauillard","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.016_b0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/humrep\/deh560","article-title":"The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea","volume":"20","author":"Jonard","year":"2005","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.ejogrb.2022.04.016_b0045","doi-asserted-by":"crossref","first-page":"E1045","DOI":"10.1210\/jc.2013-4250","article-title":"Anti-mullerian hormone deficiency in girls with congenital multiple pituitary hormone deficiency","volume":"99","author":"Deubzer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejogrb.2022.04.016_b0050","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/09513590.2017.1395842","article-title":"Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function","volume":"34","author":"Carmina","year":"2018","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.016_b0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/09513590.2011.579664","article-title":"Serum anti-M\u00fcllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa","volume":"28","author":"Luisi","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.04.016_b0060","doi-asserted-by":"crossref","first-page":"e2008","DOI":"10.1210\/clinem\/dgaa116","article-title":"Anti-M\u00fcllerian hormone and ovarian morphology in women with hypothalamic hypogonadism","volume":"105","author":"Alemyar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.ejogrb.2022.04.016_b0065","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10815-012-9759-1","article-title":"Serum anti-Mullerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism","volume":"29","author":"S\u00f6nmezer","year":"2012","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.04.016_b0070","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.fertnstert.2011.06.016","article-title":"Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea","volume":"96","author":"Li","year":"2011","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.04.016_b0075","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.fertnstert.2005.10.057","article-title":"Serum anti-m\u00fcllerian hormone levels in women with secondary amenorrhea","volume":"85","author":"La Marca","year":"2006","journal-title":"Fertil Steril"},{"issue":"12","key":"10.1016\/j.ejogrb.2022.04.016_b0080","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/humrep\/deh508","article-title":"Anti-M\u00fcllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation","volume":"19","author":"La Marca","year":"2004","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.016_b0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter-and intra-cycle variability of anti-M\u00fcllerian hormone and antral follicle counts","volume":"25","author":"van Disseldorp","year":"2010","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.ejogrb.2022.04.016_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-2-31","article-title":"The physiology of follicle selection","volume":"2","author":"Zeleznik","year":"2004","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"10.1016\/j.ejogrb.2022.04.016_b0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0300-595X(78)80005-X","article-title":"Follicular growth in fetal and prepubertal ovaries of humans and other primates","volume":"7","author":"Peters","year":"1978","journal-title":"Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ejogrb.2022.04.016_b0100","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1210\/mend.13.11.0370","article-title":"New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype","volume":"13","author":"Touraine","year":"1999","journal-title":"Mol Endocrinol"},{"issue":"5","key":"10.1016\/j.ejogrb.2022.04.016_b0105","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/ajo.12647","article-title":"Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome","volume":"57","author":"Bradbury","year":"2017","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.04.016_b0110","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2010.02.029","article-title":"The use of anti-M\u00fcllerian hormone and antral follicle count to predict the potential of oocytes and embryos","volume":"150","author":"Majumder","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Bio"},{"issue":"11","key":"10.1016\/j.ejogrb.2022.04.016_b0115","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1210\/jc.2012-1836","article-title":"Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea","volume":"97","author":"Robin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ejogrb.2022.04.016_b0120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.rbmo.2012.03.010","article-title":"Anti-M\u00fcllerian hormone in women with hypopituitarism diagnosed before or during adolescence","volume":"25","author":"Sonntag","year":"2012","journal-title":"Reprod Biomed Online"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522003074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211522003074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:56:34Z","timestamp":1759557394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211522003074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":24,"alternative-id":["S0301211522003074"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.04.016","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-M\u00fcllerian hormone, an ovarian reserve marker in hypogonadotropic hypogonadism","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2022.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}